FDA 483 - Bora Pharmaceuticals Injectables Inc - March 20, 2026

This document outlines the legal and regulatory framework for an FDA Form 483 inspection, issued pursuant to Section 704(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act. While the provided text does not specify a particular company name or inspection dates, it establishes the standard procedure for federal inspections of facilities such as factories, warehouses, and laboratories. The document functions as a formal report of objectionable conditions observed by FDA officials during their assessment of an establishment. The primary focus of these observations is to identify whether products—including food, drugs, devices, or cosmetics—are contaminated or have been handled under unsanitary conditions that could prove injurious to public health. By documenting these issues, the FDA aims to assist businesses in complying with federal safety standards and to prevent the distribution of adulterated goods. Per regulatory requirements, the inspector must provide a written copy of these findings to the facility"s management or agent in charge before leaving the premises. This ensures that the establishment is immediately notified of potential violations and can begin necessary corrective actions. Furthermore, a copy of the report is submitted to the Secretary to maintain official records of the inspection and the facility"s compliance status.